Asia-Pacific Infection Control Market, By Product (Sterilization, Cleaning and Disinfection, Personal Protective Barriers, Endoscope Reprocessing, Anti-Microbial Surfaces, Other Infection Control), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others) – Industry Trends and Forecast to 2030.
Asia-Pacific Infection Control Market Analysis and Size
The market is primarily driven by an increase in the number of surgical procedures that necessitate high-intensity infection prevention. The high preference is due to positive clinical outcomes associated with infection control use. The covid-19 pandemic has boosted market growth by increasing demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device companies.
Data Bridge Market Research analyses that the infection control market which is USD 9.44 billion in 2022, is expected to reach USD 28.88 billion by 2030, at a CAGR of 15.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Infection Control Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Sterilization, Cleaning and Disinfection, Personal Protective Barriers, Endoscope Reprocessing, Anti-Microbial Surfaces, Other Infection Control), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
STERIS plc (U.S.), Sotera Health Company (U.S.), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (U.S.), Ecolab Inc. (U.S.), 3M (U.S.), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (U.K.), Metrex Research LLC (U.K.), Miele Group (Germany), Pal International (U.K.), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (U.S.), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (U.S.), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
|
|
Market Opportunities
|
|
Market Definition
The Centers for Disease Control and Prevention have established strict hygiene guidelines for home care workers. These recommendations call for frequent hand washing with soap and water, even if the hands are not visibly soiled. To achieve thorough cleansing, lather the hands for 15 seconds.
Asia-Pacific Infection Control Market Dynamics
Drivers
- Rising Government organizations
Government organizations are increasingly involved in issuing guidelines to raise awareness about effective prevention measures around the world, which contributes to market growth during the forecast period. For instance, the World Health Organization (WHO) has issued guidelines in healthcare for the prevention and control of pandemic and epidemic-prone acute respiratory diseases. The guidelines cover everything from standard precautions such as hand hygiene and the use of personal protective equipment to disinfection and sterilization procedures.
- Increase in hospitalization
The increase in hospitalization duration with surgical infections was found to be approximately 8 days, according to a practical guide published by the WHO on the prevention of HAI. These extended stays are expected to contribute significantly to the overall costs incurred during the hospitalization period, raising the clinical urgency for infection prevention measures to be implemented. It is assumed that a prolonged hospital stay is also not cost-effective for hospitals and healthcare payers due to the excessive use of resources to treat the acquired infection. These additional costs are primarily caused by increased drug usage, additional diagnostic studies, and laboratory equipment, resulting in a resource allocation imbalance.
Opportunities
- Rising adoption of single-use medical nonwovens and devices
The number of surgical procedures performed each year has increased significantly due to an ageing population and an increase in the prevalence of obesity and diabetes. As a result, there is a greater demand for disposable medical products or single-use products that can be discarded after use, reducing the risk of infection transmission. The increasing importance of maintaining hygiene and sterility, as well as rising per capita healthcare spending, are expected to drive demand for single-use medical nonwoven products. The emergence of pandemics such as H1N1, SARS, and COVID-19, as well as viral diseases such as Zika virus, yellow fever, Ebola, and dengue fever, has increased demand for single-use medical nonwoven products.
Restraints/Challenges
- Concerns about the safety of the processed instruments
Concerns about the safety of the processed instruments used in surgeries are extremely dangerous for patients as well as healthcare workers or professionals, resulting in the spread of infection and acting as a restraint factor, hampering the growth of the infection control market.
This infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, Getinge AB launched superfast indicators to further ensure patient safety. The new Superfast 20 indicators are ISO 11138 compliant and compatible with most steam and hydrogen peroxide process sterilizers. This product launch will assist the company in increasing its market share in the global patient safety market.
- In 2019, Cardinal Health announced the acquisition of mscripts, which provides patient adherence and engagement solutions through an innovative, user-friendly mobile and web-based health management platform. This will assist the company in promoting patient adherence to prescriptions and improving overall health outcomes.
Asia-Pacific Infection Control Market Scope
The infection control market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterilization
- Cleaning and Disinfection
- Personal Protective Barriers
- Endoscope Reprocessing
- Anti-Microbial Surfaces
- Other Infection Control
Application
- Surgical Instruments
- Endoscopes
- Ultrasound Probes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
End User
- Hospitals
- Clinics
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Laboratories
- Others
Infection Control Market Regional Analysis/Insights
The infection control market is analyzed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.
The countries covered in the infection control market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing number of companies and the increasing adoption of infection control products. Due to the COVID 19 outbreak, the demand for infection control products has rapidly increased in China and India, playing a significant role in the growth of the Asia-Pacific infection control market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infection control market. The data is available for historic period 2011-2021.
Competitive Landscape and Infection Control Market Share Analysis
The infection control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infection control market.
Some of the major players operating in the infection control market are:
- STERIS plc (U.S.)
- Sotera Health Company (U.S.)
- Getinge AB (Sweden)
- Advanced Sterilization Products (ASP) (U.S.)
- Ecolab Inc. (U.S.)
- 3M (U.S.)
- MATACHANA GROUP (Spain)
- MMM Group (Germany)
- Belimed AG (Switzerland)
- Reckitt Benckiser (U.K.)
- Metrex Research LLC (U.K.)
- Miele Group (Germany)
- Pal International (U.K.)
- MELAG Medizintechnik GmbH & Co. KG (Germany)
- Contec, Inc. (U.S.)
- MEDALKAN (Greece)
- Systec GmbH (Germany)
- C.B.M. S.r.l. Medical Equipment (Italy)
- Continental Equipment Company (U.S.)
- BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
SKU-